Skip to main content

Research Repository

Advanced Search

sFRPs as a novel modulator of diastolic heart failure

People Involved

Doctor Sarah Walsh s.walsh@rgu.ac.uk
Research Fellow

Professor Cherry Wainwright c.wainwright@rgu.ac.uk
Professor

Project Description

Following a heart attack, or because of persistently high blood pressure the heart is damaged and has to work harder to circulate blood around the body. This condition is known as heart failure. In the UK alone, 500,000 people have heart failure resulting in 150,000 inpatient episodes in 2012/2013.

The aims of this research project are to increase our understanding of what roles sFRPs play in the heart and determine whether changes in the activity of sFRPs are associated with diastolic heart failure and investigate whether sFRPs represent a novel therapy for the treatment of this condition.

In partnership with Astra Zeneca

Type of Project Project
Status Project Live
Funder(s) Medical Research Council
Value £91,268.00
Project Dates Oct 1, 2017 - Sep 30, 2021
Partner Organisations AstraZeneca

You might also like

Defining the emerging roles of GPR55 Oct 1, 2019 - Sep 30, 2021
The G-protein coupled receptor (GPCR) superfamily play crucial roles in cell communication. Given their involvement in neurological disorders, inflammatory and metabolic diseases, diabetes and cardiac dysfunction they represent the largest and most s... Read More